Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EMSAM safely and effectively. See full prescribing information for EMSAM. EMSAM® (selegiline transdermal system) Initial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
EMSAM (selegiline transdermal system) is a monoamine oxidase inhibitor (MAOI) indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies (14)].
- generic_name
- selegiline
- product_names
- selegiline
- ndc
- 49502-900, 49502-900-01, 49502-900-30, 49502-900-11, 49502-900-05, 49502-901, 49502-901-01, 49502-901-30, 49502-902, 49502-902-01, 49502-902-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en